https://www.selleckchem.com/products/MK-1775.html
both Aflibercept-Fixed and Ranibizumab-TE regimens achieving the same higher final VA. Aflibercept-Fixed dosing may have more favorable efficacy with the highest VA gain and comparatively lower dosing frequency whereas Ranibizumab-TE may be more efficient than Ranibizumab-PRN regimen, according to our study. To identify factors associated with the prognosis in keratitis. The medical records of 25 patients (26 eyes) diagnosed with keratitis at a referral institution were reviewed. The demographic and clinical characteristics, t
Like
Comment
Share
